Joseph F. Lovett

Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA.

Calosyn Pharma, Inc. develops intra-articular therapeutics for osteoarthritis. Its product is based on a class of drugs known as calcium channel blockers. The firm's drugs is used in humans for the treatment of heart and vascular diseases. The company was founded by David D. Waddell and is headquartered in Atlanta, GA.

Esperance Pharmaceuticals, Inc. develops oncology products. It specializes in oncology products that selectively kill cancer cells without harming normal cells. The company was founded by Hector W. Alila in 2006 and is headquartered in Baton Rouge, LA.

Dowley Security Systems, Inc. provides electronic security and network integration solutions to critical infrastructure and commercial markets. Its services include access control, intrusion detection/monitoring, video surveillance, fire alarm and fire suppression, locksmithing, network infrastructure and integration, project management, service on-call, and budgeted maintenance. The company was founded by Daniel R. Weiss in 1986 and is headquartered in Houston, TX.

Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA.

LBRV Ventures LP (Louisiana Funds) is a venture capital firm founded in 2004. The firm is headquartered in Baton Rouge, Louisiana.

BioStable Science & Engineering, Inc. engagses in the develop of products for the treatment of cardiovascular disease. It covers areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. The firm provides a competitive edge by minimizing time to market for cost effective medical devices that deliver improved clinical outcomes. The company was founded by Al Alan Beavan, Charles D. Griffin, Douglas Charles Frank, Don James, J. Scott Rankin and Rusty Phillips in 2008 and is headquartered in Austin, TX.

NuPotential, Inc. engages in the discovery and development of novel drugs that modulate epigenetic targets and their processes for the treatment of cancer. It specializes in producing de-differentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers. The company was founded by Kenneth J. Eilertsen and Charles Oehler in 2007 and is headquartered in Baton Rouge, LA.